Briefing Information for the March 18, 2009 Meeting of the Cardiovascular and Renal Drugs Advisory Committee
Vision impaired people having problems accessing certain pages of a PDF file
may call (301) 796-3634 for assistance
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).
FDA Briefing Material [PDF]
The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
Briefing Material [PDF]